Prognostic Enrichment is a clinical trial strategy of evaluating an intervention in a patient population with a higher rate of the unwanted event than the broader patient population (R. Temple (2010) <DOI:10.1038/clpt.2010.233>). A higher event rate translates to a lower sample size for the clinical trial, which can have both practical and ethical advantages. This package is a tool to help evaluate biomarkers for prognostic enrichment of clinical trials.
|Author||Jeremy Roth [cre, aut], Kathleen F. Kerr [aut], Kehao Zhu [aut]|
|Date of publication||2017-02-17 22:15:12|
|Maintainer||Jeremy Roth <firstname.lastname@example.org>|
|License||GPL (>= 2)|
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.